Healthcare regulations haven’t kept pace with the speeding uptake of artificial intelligence in hospitals and clinics, doctors have warned, leaving industry workers at risk of being sued for mistakes...
Health and Med Tech
Posted on
| by Justin Hendry
Cynata Therapeutics has laid off its entire staff after a clinical trial of its stem cell therapy failed to outperform a placebo, dealing a fresh blow to the Melbourne-based...
Posted on
| by Justin Hendry
New Zealand biotech BioOra will expand production of its next-generation cell therapies to Australia after winning a $7.7 million grant through Queensland’s Sovereign Industry Development Fund. The Wellington-based company...
Posted on
| by Pam Ramali
The next generation of obesity and diabetes trials are being run out of Australia. Sponsors who once defaulted to the US or Europe are increasingly choosing us. The question...
Posted on
| by David Allen
A new federal taskforce overseeing synthetic biology and artificial intelligence is a welcome step, but Australia remains dangerously ill-equipped to handle the technology’s biosecurity threats, experts have warned. Former...
Posted on
| by David Allen
Archer Materials has taken a step forward in its development of a tiny biomedical device that could soon be all that’s needed to analyse simple substances and eventually make...
Posted on
| by David Kirton
An American scientist convicted of lying to US authorities about payments from China while he was at Harvard University has rebuilt his research lab in Shenzhen to pursue technology...
Posted on
| by David Allen
Seven Victorian startups developing healthcare solutions ranging from 4D lung imaging to AI-enabled bedsore prevention will join MTPConnect’s capability accelerator program, which is exploring a tilt into other states....
Posted on
| by David Allen
A digital tool designed to monitor artificial intelligence adoption across the healthcare sector will reach an advanced prototype stage by the end of the year, according to the Digital...
Posted on
| by David Allen
Healthcare providers will be able to access individual patients’ medication histories in real-time, the federal government pledged Wednesday, to reduce medication errors, adverse drug reactions or inappropriate use. Health...
Posted on
| by David Allen
The National Reconstruction Fund Corporation (NRFC) has taken a $20 million preferred equity stake in a Sydney neurotechnology startup to help fund its plans for local research infrastructure and...
Posted on
| by Joseph Brookes
Australia’s subscale capabilities in developing new drugs will need smart policy and emerging tech to bridge the decade-long divide between medical research and commercialisation. That’s according to Dr Craig...
Posted on
| by Pam Ramali
When biotechs and major pharma companies need to fast-track early drug trials, they’re increasingly skipping Boston and California and choosing Melbourne instead. They can begin enrolling patients within weeks,...
Posted on
| by Trish Everingham
A $600 million health research facility has opened at the University of NSW’s Randwick campus, bringing together researchers, clinicians and students under one roof for the first time. The...